Tropomyosin-Troponin Regulation of Actin Does Not Involve Subdomain 2 Motions*

Jack H. GersonDagger , Eldar KimDagger , Andras Muhlrad§, and Emil ReislerDagger ||

From the Dagger  Department of Chemistry and Biochemistry and the  Molecular Biology Institute, University of California, Los Angeles, California 90095 and the § Department of Oral Biology, Hebrew University-Hadassah School of Dental Medicine, Jerusalem 91120, Israel

Received for publication, December 8, 2000, and in revised form, February 20, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Dynamic properties of F-actin structure prompted suggestions (Squire, J. M., and Morris, E. P. (1998) FASEB J. 12, 761-771) that actin subdomain 2 movements play a role in thin-filament regulation. Using fluorescently labeled yeast actin mutants Q41C, Q41C/C374S, and D51C/C374S and azidonitrophenyl putrescine (ANP) Gln41-labeled alpha -actin, we monitored regulation-linked changes in subdomain 2. These actins had fully regulated acto-S1 ATPase activities, and emission spectra of regulated Q41CAEDANS/C374S and D51CAEDANS/C374S filaments did not reveal any calcium-dependent changes. Fluorescence energy transfer in these F-actins mostly occurred from Trp340 and Trp356 to 5-(2((acetyl)amino)ethyl)amino-naphthalene-1-sulfonate (AEDANS)-labeled Cys41 or Cys51 of adjacent same strand protomers. Our results show that fluorescence energy transfer between these residues is similar in the mostly blocked (-Ca2+) and closed (+Ca2+) states. Ca2+ also had no effect on the excimer band in the pyrene-labeled Q41C-regulated actin, indicating virtually no change in the overlap of pyrenes on Cys41 and Cys374. ANP quenching of rhodamine phalloidin fluorescence showed that neither Ca2+ nor S1 binding to regulated alpha -actin affects the phalloidin-probe distance. Taken together, our results indicate that transitions between the blocked, closed, and open regulatory states involve no significant subdomain 2 movements, and, since the cross-linked alpha -actin remains fully regulated, that subdomain 2 motions are not essential for actin regulation.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Descriptions of the molecular mechanism of muscle function tend to focus on the dynamic properties of the myosin motor or the steric shift of the tropomyosin/troponin (Tm1·Tn) complex on actin. Actin appears to take the role of a static, rigid lattice upon which the other muscle proteins shift in order to produce and regulate muscle movement. However, with numerous studies showing the dynamic nature of filamentous actin (F-actin), this may not, in fact, be the case. F-actin, depending on the ligands bound and/or the stage in the cross-bridge cycle, becomes more or less flexible (2, 3), twists on its axis (4, 5), and goes through marked structural changes at the C terminus (6-8), and in subdomain 2 (3, 9, 10). Molecular modeling and biochemical studies of F-actin indicate that the C terminus and subdomain 2 are part of the intermolecular interface (11-20). There is also evidence, both modeling (21) and biochemical (22, 23), indicating direct or indirect interactions between subdomain 2 and the myosin head (S1). Modifications of the C-terminal Cys374 are also known to cause reagent-dependent changes in the actomyosin ATPase activity and the in vitro motility of actin filaments (7). Thus, there are certainly strong indications that the dynamic properties of actin in general, and of subdomain 2 in particular, may play important roles in actomyosin interactions.

The position of Tm on F-actin has been modeled to a high degree of resolution (13, 24-27). Residues likely involved in Tm-F-actin interactions, as suggested by these models, are all located in subdomains 3 and 4. While subdomain 2 does not seem to be involved in the Tm-F-actin interaction, an interesting biochemical study by Bonafé et al. (28) implicates (either through direct or indirect effects) the DNase I loop of subdomain 2 in such an interaction. In this study the presence of Tm and the Tm·Tn complex interfered with the cross-linking of Lys50 of actin to the central 48 kDa of the S1 heavy chain. This inhibition of cross-linking indicates Tm- and Tm/Tn-induced changes in either the reactivities of, and/or the distances between, the cross-linking sites on actin and S1. A more explicit suggestion of subdomain 2 movement during actin regulation was advanced by Squire and Morris (1) in their review on muscle thin filament regulation. According to their hypothesis, the structural changes seen in electron microscopy and x-ray diffraction studies of regulated thin filaments may be due not only to shifts of the Tm·Tn complex, but also to subdomain movements within each actin protomer. This hypothesis, together with the results of Bonafé et al. (28), prompted us to examine the role of subdomain 2 movements in the regulatory process.

To study the role of subdomain 2 in the Tm/Tn regulation of actomyosin, we attached fluorescent probes (1,5-IAEDANS or pyrene maleimide) to three fully functional mutant yeast actins, Q41C/C374S, D51C/C374S, and Q41C at positions 41 or 51, and in the case of Q41C, also at position 374 (Fig. 1). The first two mutants have the reactive Cys374 replaced by Ser and new reactive cysteine residues replacing Gln41 and Asp51, respectively. The third mutant retains the reactive Cys374 while adding an additional reactive cysteine in place of Gln41. Using these labeled mutants, we monitored their fluorescence by means of direct excitation, energy transfer, and, in the case of the doubly labeled Q41C, excimer fluorescence during the various regulatory steps. We also used Gln41/ANP (azidonitrophenyl putrescine)-labeled alpha -skeletal actin (both cross-linked and uncross-linked) in conjunction with rhodamine phalloidin, and in this way, measured the quenching of rhodamine fluorescence by ANP during regulation. Also, using the cross-linked species, we were able to investigate the regulatory properties of F-actin with an immobilized subdomain 2.

Our results show that there are no significant changes in the probe environment, nor in the relative position of subdomain 2, in the course of Ca2+ regulation by Tm/Tn. In addition, we found that despite intrastrand cross-linking, the ANP-labeled alpha -skeletal actin remained fully regulated, indicating that a mobile subdomain 2 is not a necessary component in actomyosin regulation.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents-- ATP, ADP, dextrose, DTT, phalloidin, and phenylmethylsulfonyl fluoride were purchased from Sigma. 5-(2((Iodoacetyl) amino)ethyl)aminonaphthalene-1-sulfonate (1,5-IAEDANS) and N-(1-pyrene)maleimide were purchased from Molecular Probes, Inc. (Eugene, OR). The QuikChangeTM site-directed mutagenesis kit, DNA restriction enzymes, and plasmid purification kit were purchased from Stratagene (La Jolla, CA), New England Biolabs (Beverly, MA), and Qiagen (Valencia, CA), respectively. Yeast extract and tryptone were purchased from Difco (Detroit, MI). DNase I was purchased from Worthington Biochemical Co. (Lakewood, NJ). N-(4-Azido-2-nitrophenyl)-putrescine (ANP) was a generous gift from Dr. G. Hegyi.

Oligonucleotide-directed Mutagenesis-- The mutagenesis was performed according to the Stratagene (La Jolla, CA) QuikChangeTM procedure using oligonucleotides purchased from Genset Corp. (San Diego, CA). As a template for the mutagenesis we used double stranded yeast shuttle plasmid pTD24 (29), which carries a copy of the ACT1 gene. Two oligonucleotide primers, 5'-GGGTCAAAAAtgtTCCTACGTTGG-3' and 5'-CCAACGTAGGAacaTTTTTGACCC-3', were used to introduce the D51C actin mutation. Two primers, 5'-CAGAGATTAGAAgcttTTGTGGTGAAC-3' and 5'-GTTCACCACAAaagcTTCTAATCTCTG-3', were used to generate the C374S actin mutation. The mutated sequences are shown in lowercase and the selective restriction enzyme markers are underlined (in D51C the PleI site is lost while in C374S the HindIII is added). Actin genes from screened plasmid clones were sequenced (GeneMed, San Francisco, CA) to confirm the absence of random errors. The construction of the Q41C and Q41C/C374S mutants was reported in a previous publication (20).

Yeast Transformation-- Mutant plasmids carrying the HIS3 marker were transformed into the diploid yeast strain TDS101 (29) that has a single ACT1 gene copy on the plasmid with a URA3 marker and genomic copies of the ACT1 gene deleted. The original plasmid carrying the ACT1 gene was sorted out by plasmid shuffling (30). The cells were screened for HIS plus and URA minus phenotype, which resulted in yeast cells carrying a homozygous copy of the mutated actin gene.

Proteins-- Skeletal myosin and actin were prepared from rabbit back muscle according to Godfrey and Harrington (31) and Spudich and Watt (32), respectively. S1 and heavy meromyosin were prepared from myosin using the protocols of Weeds and Pope (33) and Kron et al. (34), respectively. The cardiac troponin and tropomyosin were generous gifts from Dr. L. Tobacman. Ca2+-independent bacterial transglutaminase was a generous gift of Dr. K. Seguro, Ajimoto Co., Inc. Japan. Yeast actins were purified over a DNase I affinity column (35). To avoid possible contamination of yeast actin with cofilin, the DNase I column was washed with 1.0 M NaCl in G-actin buffer (5 mM TES, 0.2 mM CaCl2, 0.2 mM ATP, 1.0 mM DTT, pH 7.5) (36) prior to the elution of yeast actin. After elution, the purified actins were stored on ice in G-actin buffer.

The labeling of both Q41C/C374S and D51C/C374S actin mutants with 1,5-IAEDANS was done in the following manner. After elution from DNase I column, actin was exchanged into a DTT-free G-actin buffer using Sephadex G-50 spin columns. A 1.3-fold molar excess of 1,5-IAEDANS dissolved in N,N-dimethylformamide was added to the actin and the airspace was then purged with N2. The reaction, which was allowed to proceed overnight on ice, was stopped with an excess of DTT. The labeled actin was further purified via a polymerization-depolymerization cycle. An extinction coefficient of 5700 M-1 cm-1 was used to determine the degree of labeling, which was generally in excess of 90%. The labeling of Q41C, which has two reactive cysteines, Cys41 and Cys374, with pyrene maleimide was performed according to a previously described protocol (37). The extent of labeling was ~1.8 pyrene maleimide/actin.

The ANP-labeled and uncross-linked skeletal actin was prepared using a procedure based on that of Hegyi et al. (18). 1.0 mg/ml G-actin in 5.0 mM Tris-HCl, 0.2 mM CaCl2, and 0.4 mM ATP, pH 8.0, was incubated with 0.1 mM ANP and 0.4 unit/ml bacterial transglutaminase at room temperature, in the dark, for 2 h. This solution was placed under a stream of N2 for 7 min to remove the dissolved O2. To quench the attached ANP and prevent a cross-linking reaction, 2.0 mM DTT was added to actin prior to its UV irradiation with a Model C-62 UV Illuminator (Ultra-Violet Products Inc., San Gabriel, CA) under a constant N2 stream (for 7 min). The labeled sample was polymerized by the addition of 2.0 mM MgCl2. The resulting F-actin was pelleted by centrifugation at 40,000 rpm in a Beckman Ti 70 rotor, incubated on ice for 2 h, and homogenized in 5 mM Tris-HCl, pH 8.0, 2 mM MgCl2, and 0.2 mM ATP. The degree of actin labeling was 98 ± 5%. The preparation of ANP-labeled and cross-linked F-actin proceeded similarly. G-actin was labeled by incubating with ANP and bacterial transglutaminase and was immediately polymerized by 2.0 mM MgCl2. The labeled F-actin was pelleted and homogenized in 5.0 mM Tris-HCl, pH 8.0, 2 mM MgCl2, and 0.2 mM ATP. After homogenization it was placed under N2 stream and then irradiated by UV light as described above, except for the absence of DTT. The level of cross-linking achieved was ~85%.

Regulated Actin-activated ATPase-- The rates of S1 Mg-ATPase activated by regulated actin ± Ca2+ were obtained as described previously (38) using light scattering to monitor the clearing time of regulated F-acto-S1 solutions. Thin filaments were reconstituted using bovine cardiac troponin, and bovine cardiac tropomyosin and each of the following actins: wild type, Q41C/C374S, Q41CAEDANS/C374S, D51C/C374S, D51CAEDANS/C374S, Q41C, Q41Cpyrene, and skeletal alpha -actin ANP. The concentrations of actin, Tm, Tn, and S1 were 4.0, 2.0, 1.0, and 1.0 µM, respectively. Experiments were carried out at 23 °C using a Mg-ATP concentration of 0.1 mM and either 1.0 mM EGTA or 0.2 mM CaCl2. The course of Mg-ATP hydrolysis was monitored by measuring the light scattering at 350 nm from the above solutions (38) in a Spex Fluorolog (Spex Industries Inc., Edison, NJ).

Actin Polymerization-- Polymerization of the G-actins (4.0 µM) by MgCl2 (3.0 mM) was monitored by measuring light scattering from actin solutions in a Spex Fluorolog set at 325 nm.

Fluorescence Measurements-- Fluorescence emissions spectra for the labeled actins were recorded at 23 °C in Spex Fluorolog using excitation wavelengths of 338 nm for direct excitation of the AEDANS probe and 295 nm for measurements of energy transfer from tryptophan residues to the probes. For monitoring the pyrene excimer formed in Q41Cpyrene F-actin (37), the excitation wavelength was set at 344 nm. For measurements of rhodamine quenching in ANP-labeled actin, an excitation wavelength of 554 nm was used. Acrylamide quenching measurements of AEDANS-labeled actins were carried out using an excitation wavelength of 338 nm and an emission wavelength of 492 nm. Acrylamide was added in 10 mM increments and the data were fitted to the Stern-Volmer equation (39) in order to determine the quenching constant KSV. The concentrations of actin, Tm, Tn, and S1 used in fluorescence experiments were 4.0, 2.0, 1.0, and 1.0 µM, respectively, unless stated otherwise. Yeast actin was stabilized by equimolar amounts of phalloidin.

In Vitro Motility Assays-- The in vitro motility assays were performed according to a previously described protocol (29). Movement was initiated by applying an assay buffer (25 mM KCl, 1.0 mM EGTA, 5.0 mM MgCl2, 10 mM DTT, 0.2% methylcellulose, 10 mM imidazole, pH 7.4) containing 1.0 mM ATP and an oxygen scavenging system (40). An ExpertVision System (Motion Analysis, Santa Rosa, CA) was used to quantify the sliding speeds of individual filaments. Individual filaments were judged to be moving smoothly and were used for statistical analysis if the standard deviation of their sliding speeds was less than one-third of their average velocity (41).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The Actins and Their Function-- The flexibility of subdomain 2 in actin has been demonstrated by a number of studies (3, 9, 10) and there is evidence indicating that Tm has a sufficient influence on either this subunit or on the S1 bound to actin to abrogate their cross-linking (28). To test for possible changes in the conformational states of subdomain 2 due to regulatory proteins and the regulation of actin, we employed three fluorescently labeled actin mutants of subdomain 2 and Gln41-labeled skeletal alpha -actin (Table I, Fig. 1). All the polymerized actins used in this study, whether labeled or unlabeled, had fully regulated acto-S1 ATPase activities when complexed with Tm/Tn. Ca2+-induced activation of acto-S1 ATPase, as measured by the ratio of MgATPase activities in the presence of 0.2 mM Ca2+ and 1.0 mM EGTA, ranged between 10- and 16-fold for these actins (Table I), except for the double labeled Q41C actin, which showed 5-fold activation (Table I). The courses of Mg2+-induced polymerization of the actins, both labeled and unlabeled, were similar, as were the speeds of the yeast actin filaments in the in vitro motility assays (3.0 ± 0.3 µm/s). Previous work showed that ANP labeling of alpha -actin at Gln41 had no significant effect on its in vitro motility, while the intermolecular cross-linking by this reagent between residues Gln41 and Cys374 strongly impaired in vitro motility (42).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Labeled actins used in this study and their regulation


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   A, two protomers from the F-actin model of Holmes et al. (48) showing the locations of residues 41 (red), 51 (blue), and 374 (black), all of which were mutation sites in the yeast actins. The turquoise residues represent, from left to right, Trp340 and Trp356, while the violet residues represent Trp86 and Trp79 (left to right). B, enlarged diagram showing the spatial relationship between tryptophan residues 340 and 356 (turquoise) and 86 and 79 (violet), and the locations on yeast actin where AEDANS probes were attached (residues 41 (red) and 51 (blue)). The distances (Å) of the closest tryptophans (79 and 86 on the same protomer and 340 and 356 on the adjacent protomer) to residue 41 are shown as examples.

Emission Spectra of Unregulated Q41CAEDANS/C374S and D51CAEDANS/C374S-- We monitored the fluorescence of the two AEDANS-labeled yeast actin mutants with an excitation wavelength of 338 nm (Figs. 2, A and B). Polymerization of Q41CAEDANS/C374S Ca2+-G-actin was accompanied by a marked increase in the fluorescence and a blue shift of ~9 nm (from a lambda max of 495 nm for G- to a lambda max of 486 nm for F-Q41CAEDANS/C374S) (Fig. 2A), indicating the withdrawal of the probe from a more aqueous to a more hydrophobic environment. These changes are qualitatively similar to the changes observed for dansylethylenediamine attached to Gln41 in alpha -actin (43, 44).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Emission spectra of AEDANS-labeled Q41C/C374S and D51C/C374S mutant yeast actins. The spectra (in arbitrary units) were recorded at 23 °C using an excitation wavelength of 338 nm. The concentrations of actin, Tm, and Tn were 4.0, 2.0, and 1.0 µM, respectively. Ca2+ and EGTA (for the -Ca2+ state) concentrations were 0.2 and 1.0 mM, respectively. A, the emission spectrum of Q41CAEDANS/C374S Ca2+-G-actin (solid line) has lambda max of 495 nm. Emission spectra of F-actin alone and F-actin with Tm or Tm-Tn ± Ca2+ were identical, with a lambda max of 486 nm, and are represented by a single line (dashed). B, emission spectra of D51CAEDANS/C374S Ca2+-G-actin (solid line), F-actin alone and with Tm (dashed line), and F-actin with Tm-Tn ± Ca2+ (dash-dotted line). The lambda max for all three plots is 494 nm.

The polymerization of D51CAEDANS/C374S Ca2+-G-actin decreased the AEDANS fluorescence significantly (solid and dashed line spectra in Fig. 2B) with no discernible shift in lambda max (494 nm). This could indicate an extension of the probe into a more aqueous environment. To test the possibility of shifts to different environments for probes at Cys41 and Cys51, we performed fluorescence titration experiments using acrylamide as the quenching agent. The Stern-Volmer constants for the two Ca2+-G-actins were very similar; 8.4 M-1 for Q41CAEDANS/C374S and 8.5 M-1 for D51CAEDANS/C374S, showing equal accessibility of the probes at Cys41 and Cys51 to acrylamide. For the F-actins the Stern-Volmer constants were different, 4.7 M-1 for Q41CAEDANS/C374S versus 5.9 M-1 for D51CAEDANS/C374S. This suggests that at both locations AEDANS is buried upon actin polymerization, albeit to a smaller degree at Cys41 than at Cys51.

Emission Scans of Regulated Q41CAEDANS/C374S-- To test for possible subdomain 2 changes that would account for the effect of Tm on S1 cross-linking to Lys50 on actin (28), we examined the fluorescence of the probe at Cys41 under regulatory conditions corresponding to the blocked and closed states of the McKillop and Geeves (46) three-state model. The sequential additions of Tm, Tm/Tn + Ca2+ (both resulting in the predominantly closed state (13, 46)), and Tm/Tn - Ca2+ (blocked state) had virtually no effect on the fluorescence spectra of F-actin, justifying their visually simplified representation by a single emission spectrum in Fig. 2A (dashed line).

Fluorescence Resonance Energy Transfer (FRET) in Unregulated and Regulated Q41CAEDANS/C374S-- While the shift from the blocked to closed state may not significantly impact probe fluorescence, this still does not preclude a shift of subdomain 2 of actin, relative to the rest of the molecule, during regulation. We therefore monitored the energy transfer from tryptophan residues to the AEDANS acceptor on Cys41 (Fig. 1). Based on the tryptophan substitution study of Doyle et al. (45) that revealed only small contributions of Trp79 (~1%) and Trp86 (~11%) to total actin fluorescence, and the relative proximity to the probe of Trp340 and Trp356 in same-strand actin protomers adjacent to (above) the labeled actins (Fig. 1), these last two tryptophan residues appear to be major energy donors to AEDANS on Cys41 (see "Discussion"). As shown in Fig. 3A, the presence of AEDANS on Cys41 led to a decrease in tryptophan fluorescence for both G-actin and F-actin. Since the decrease in tryptophan emission was much larger in F-actin than in G-actin, polymerization increases energy transfer from the tryptophans to the AEDANS probe. This increase in energy transfer can be accounted for by the contribution of Trp340 and Trp356 on the adjacent actin protomer in F-actin.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Emission spectra of AEDANS-labeled and unlabeled Q41C/C374S actin mutant using an excitation wavelength of 295 nm. The plots show tryptophan fluorescence and, in the case of the labeled actins, reveal energy transfer from tryptophan residues to the AEDANS probes positioned in subdomain 2. The concentrations of protein, Ca2+, and EGTA were the same as those listed in the legend to Fig. 2. A, spectra of Q41C/C374S and Q41CAEDANS/C374S Ca2+-G-actin (thin and thick solid line, respectively) and F-actin alone (thin and thick dashed line, respectively). B, spectra of Q41CAEDANS/C374S F-actin alone and F-actin with Tm (dashed line) and F-actin with Tm-Tn ± Ca2+ (solid line).

The addition of Tm had no effect on Q41CAEDANS/C374S F-actin emission (Fig. 3B). The formation of the F-actin·Tm·Tn complex increased tryptophan fluorescence (due to the tryptophan residues on Tn) but had no effect on AEDANS emission, both in the presence (closed state) and absence (blocked state) of Ca2+ (Fig. 3B). This evidence implies that not only does the creation of the closed state (through the addition of Tm) not change the environment of the AEDANS probe, but the regulatory shift from closed to blocked states is also not accompanied by probe movements relative to the tryptophan residues in the adjacent actin.

Excimer Fluorescence Measurements in Unregulated and Regulated Q41CPYRENE-- As a means of further investigating the possibility of dynamic transitions at the subdomain 2/1 interface in F-actin, we used the yeast actin mutant Q41C (that has two reactive cysteine residues at positions 41 and 374) labeled with pyrene (Fig. 1). Upon polymerization, the pyrene label at Cys41 forms an excimer with the label at Cys374 of the next monomer in the strand (37). Movements of subdomain 2 relative to the C terminus of the following monomer would abolish or change the excimer and thus signal changes in subdomain 2 position in the closed versus blocked regulatory states. As expected (37), the spectrum of pyrene-labeled Q41C G-actin did not show an excimer band (Fig. 4). The F-actin spectrum, however, had a decreased pyrene peak and an excimer band at lambda max = 476 nm (Fig. 4). The addition of regulatory proteins had no effect on the excimer peak, indicating no changes in the position of the stacked pyrene probes (Fig. 4). This is further evidence for the seemingly static nature of actin subdomain 2 in the transition from the blocked to closed regulatory states.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Pyrene emission spectra of the labeled yeast actin mutant Q41C. Spectra for Ca2+-G-actin (solid line), and for F-actin alone and F-actin with Tm or with Tm-Tn ± Ca2+ (dashed line) were recorded using an excitation wavelength of 344 nm. All concentrations were the same as those listed in the legend to Fig. 2.

Emission Scans of Regulated D51CAEDANS/C374S-- The second subdomain 2 mutant used in this work, D51C/C374S, gave us an additional point of reference for observing possible subdomain 2 movements during actin regulation. Furthermore, it allowed us to monitor such movements in the vicinity of a residue (Lys50) involved in a cross-linking to S1 that is inhibited by Tm (28). The addition of Tm (i.e. creation of the closed state) had no effect on the AEDANS fluorescence of F-actin (Fig. 2B, dashed line represents both F-actin and F-actin + Tm). Interestingly, the addition of Tn (leading to the formation of the F-actin·Tm·Tn complex) increased fluorescence to a point between G- and F-actin where it remained, unaffected by any shift from the closed to the blocked state (i.e. the presence or absence of Ca2+) (Fig. 2B, dashed dotted line corresponds to both states). Thus, even at a location immediately adjacent to Lys50, we did not detect any regulation-induced changes in the probe's environment.

Fluorescence Energy Transfer in Unregulated and Regulated D51CAEDANS/C374S-- As with Q41CAEDANS/C374S, we measured FRET from tryptophan residues to the AEDANS probe, which in this case was attached at residue Cys51 (Fig. 1). Here too, the decrease in tryptophan emission in the presence of the AEDANS acceptor was larger in F-actin than in G-actin (5A). This polymerization related increase in energy transfer from the tryptophans to the AEDANS probe is most likely due to the Trp340 and Trp356 donors on the adjacent protomers in F-actin.

As was the case when the AEDANS probe was directly excited, the addition of Tm had no effect on the stimulated fluorescence, while the formation of the F-actin·Tm·Tn complex increased both tryptophan and AEDANS fluorescence without any state dependent (Ca2+-related) changes in the spectra (Fig. 5B). Thus, we did not detect any "closed state"-induced changes in energy transfer efficiency, nor any movements due to shifts between the closed and blocked states of actin.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Emission spectra of AEDANS-labeled and unlabeled D51C/C374S actin mutant using an excitation wavelength of 295 nm. The plots show tryptophan fluorescence and, in the case of the labeled actins, reveal energy transfer from tryptophan residues to the AEDANS probes positioned in subdomain 2. All concentrations were the same as those listed in the legend to Fig. 2. A, spectra of D51C/C374S and D51CAEDANS/C374S G-actin (thin and thick solid line, respectively), and D51C/C374S and D51CAEDANS/C374S F-actin alone (thin and thick dashed line, respectively). B, spectra of D51CAEDANS/C374S F-actin alone and F-actin with Tm (dashed line) or with Tm-Tn ± Ca2+ (solid line).

Quenching of Rhodamine Fluorescence in Unregulated and Regulated ANP-labeled Skeletal alpha -actin-- Finally, we examined one more system that provided an additional point of reference regarding possible subdomain 2 movements, and also enabled us to evaluate all three regulatory states: blocked, closed, and open (the tryptophans of S1, which is required for the shift to the open state, would have interfered with the probes used in the previous experiments). We labeled Gln41 on skeletal alpha -actin with ANP, which is an excellent acceptor of energy from rhodamine (Fig. 6). The quenching of rhodamine phalloidin fluorescence by ANP allowed us to monitor the possible distance changes between this probe and ANP on Gln41.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Fluorescence spectra (lambda Excitation = 554 nm) of rhodamine phalloidin (2.5 µM) complexed with: 4.0 µM skeletal F-actin (solid line), ANP-labeled skeletal F-actin (dashed line), and cross-linked ANP-labeled skeletal F-actin (dash-dotted line). Inset, spectral overlap between rhodamine emission spectrum of complex of skeletal F-actin (4.0 µM) and rhodamine phalloidin (2.5 µM) (solid line) and the absorbance spectrum of 4.0 µM ANP-labeled skeletal F-actin (dashed line). Optical density (O.D.) ordinate for ANP absorbance is on the right side of the graph.

Fig. 6 shows the fluorescence of rhodamine phalloidin bound to unlabeled actin, labeled/uncross-linked actin, and labeled/cross-linked actin. We collected emission spectra for both uncross-linked and cross-linked ANP-labeled F-actin alone, in the predominantly closed (+Tm, +Tm/Tn (+Ca2+)) and blocked (+Tm/Tn (-Ca2+)) regulatory states, and for the uncross-linked species in the open (+Tm/Tn and S1) state (Table II). Our results indicate that there were no significant changes in the quenching of rhodamine fluorescence by ANP in any regulatory state, including that created in the presence of S1 (the open state). Thus, even the shift to the open state did not induce sufficient subdomain 2 movement to change the degree of rhodamine quenching by ANP.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Fluorescence intensities of rhodamine phalloidin-ANP F-actin complexes
Fluorescence intensities of rhodamine phalloidin bound to ANP-labeled (cross-linked and uncross-linked) F-actin were recorded with the excitation and emission wavelengths set at 554 and 570 nm, respectively. Fluorescence data from two separate ANP-labeled actin preparations are given in arbitrary units (A.U.). Protein concentrations for actin, Tm, Tn, and S1 were, 4.0, 2.0, 1.0, and 4.0 µM, respectively. Rhodamine phalloidin concentration was 2.5 µM, and the concentrations for Ca2+ and EGTA (for the -Ca2+ condition) were 0.2 and 1.0 mM, respectively.

Upon exposure to UV radiation the ANP moiety cross-links to Cys374 on the next actin protomer in the strand, immobilizing the DNase I loop (18). We found that the ANP cross-linked alpha -actin remained fully regulated. Heretofore, we have shown that regulation of actin is not accompanied by discernible subdomain 2 movements. The fact that the cross-linked actin remains fully regulated shows that such movements, even if present, are neither a necessary nor an important part of actin regulation.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The purpose of this study was to test the hypothesis that subdomain 2 movements are an important component of actin regulation by the Tm·Tn complex. Squire and Morris (1) raised this possibility, suggesting that changes in x-ray diffraction patterns of regulated actin could, in part, be attributed to subdomain 2 movements and not solely to the shifting of the regulatory proteins. To explore this possibility, we used labeled skeletal alpha -actin and yeast actin mutants whose reactive cysteines on the DNase I loop (Cys41 or Cys51) were labeled with fluorescent probes. We anticipated that changes in the environment of these probes and in their distance from native actin tryptophan residues would be reflected in their fluorescence and in the fluorescence energy transferred to them. While such FRET measurements between tryptophans and the AEDANS probes in actin mutants were suitable for monitoring regulatory shifts between the blocked (+Tm-Tn; -Ca2+) and the closed (+Tm-Tn; +Ca2+) states, they could not be used to investigate the open state because of the strong tryptophan fluorescence of S1. By using ANP-labeled skeletal alpha -actin, we were able to look for changes in the quenching of rhodamine phalloidin fluorescence by ANP possibly stemming from shifts between the closed and open states. In its cross-linked state, ANP-actin also allowed us to investigate whether subdomain 2 movement is required for the regulation of actin by Tm-Tn.

Functional assays of labeled alpha -actin and yeast actin mutants confirmed their suitability for testing regulation-linked changes in actin structure. All actins polymerized well and were fully regulated in acto-S1 ATPase experiments (Table I). In vitro motilities were similar for wild type and both labeled and unlabeled mutant actins. A previous study showed that uncross-linked ANP-labeled skeletal alpha -actin has sliding speeds virtually the same as those of unlabeled alpha -actin, while the sliding of cross-linked ANP-actin is impaired (42).

Emission Spectra of Labeled Yeast Actin Mutants-- As revealed by our results, adding regulatory proteins to Q41CAEDANS/C374S produced no significant changes in probe fluorescence, indicating that whatever effect Tm/Tn have on this subdomain, it is not discernible in any environmental changes of the probe. In the case of D51CAEDANS/C374S, addition of Tn to the F-actin·Tm complex increased the probe fluorescence by ~10%. Yet, since Tn is added to actin-Tm in the presence of Ca2+, there should be no shift in Tm position, as both Tm alone and the Tm·Tn complex (+Ca2+) lie in the closed state (13, 25). As the presence or absence of Tm does not change the probe environment, the small effect of Tn on AEDANS fluorescence in this actin mutant appears unrelated to the state of regulated actin. This conclusion is confirmed by the lack of fluorescence differences between the blocked (-Ca2+) and closed (+Ca2+) regulatory states of this actin, indicating an absence of regulation-dependent changes in the probes environment. At this stage, the nature of the Tn-specific and Ca2+ insensitive perturbation at the Cys51 site on actin is unclear.

The availability of the actin mutant Q41C with its two reactive cysteines, Cys41 and Cys374, allowed us to examine the subdomain 2/1 interface in regulated F-actin. Upon polymerization this double pyrene-labeled mutant exhibits an excimer, indicating the stacking of pyrene labels attached to Cys41 and Cys374 on adjacent protomers within the same filament strand (37). As reported under "Results," neither the addition of regulatory proteins nor the switch from the blocked to the closed state had any effect on the excimer fluorescence. This suggests that there is little, if any, change in the overlap of pyrene probes, and/or regulation-induced movement at the subdomain 2/1 interface in F-actin.

Fluorescence Energy Transfer Experiments-- We took advantage of the inherent sensitivity of FRET measurements to distance changes (in the donor-acceptor pair), and of the now available information on the relative fluorescence levels of the four actin tryptophans, to monitor possible subdomain 2 movements due to actin regulation.

According to the Doyle et al. (45) analysis of tryptophan yeast actin mutants, the contributions of Trp79, Trp86, Trp340, and Trp356 to actin fluorescence are 1, 11, 37, and 51%, respectively, while the R0 value for the tryptophan-AEDANS donor-acceptor pair is 22 Å (47). These contributions permit the calculation of FRET efficiency in F-actin using the distances from the tryptophans to Gln41 and Asp51 derived from the Holmes et al. (48) (Fig. 1) and Lorenz et al. (49) models of F-actin. Obviously, such calculations of intra- and inter-protomer FRET in F-actin are model-dependent and their predictive value is further reduced by the unknown orientation of AEDEANS at the Cys41 and Cys51 sites. Despite these limitations and regardless of the exact partitioning of energy transfer between the different tryptophan residues, these calculations provide strong evidence for a major contribution to FRET by the inter-protomer (on adjacent actins within the same strand) transfer of energy from Trp340 and Trp356 to AEDANS on either Cys41 on Cys51. This conclusion is consistent with the much greater efficiency of FRET in F- than in G-actin (Figs. 3A and 5A). Thus, changes in AEDANS fluorescence during excitation at 295 nm (i.e. at the tryptophan excitation band) should monitor, to a large extent, distance changes between the probe and Trp340 and Trp356 on the adjacent protomer.

Our main results show that the stimulated fluorescence of AEDANS attached to either Cys41 or Cys51 does not change upon the binding of Tm to F-actin or upon the switch of the actin·Tm·Tn complex from the blocked to the closed state (EGTA/Ca2+ switch). The fact that acceptor probes located at two different sites in subdomain 2 yield the same results regarding distance changes during Ca2+ regulation of these well regulated actins suggests that subdomain 2 remains static during this process. Our strategy of probing (by FRET) distance changes from tryptophan donors to two acceptor sites makes it unlikely that a movement of subdomain 2 escapes our detection due to compensating changes in energy transfer. Moreover, the absence of any perturbation of the pyrene excimer band in the course of regulatory transitions in Q41C yeast actin adds credence to the static picture of subdomain 2.

ANP-labeled Skeletal alpha -Actin-- Our experiments involving the yeast actin mutants were limited to evaluating two states of the "three-state model" of actin regulation (46); the blocked and closed states. The transition to the open state requires the presence of S1, which would introduce additional energy donors to the environment of the AEDANS probes on actin. We were able to surmount this complication by using ANP-labeled (at Gln41) alpha -actin and monitoring the quenching of rhodamine phalloidin fluorescence by ANP. The ANP-labeled actin allowed us to look for subdomain 2 movements during the shift to the open state since the presence of S1 has no effect on rhodamine fluorescence. Not only did this particular experiment allow us to "fill-in the gap" left by our yeast actin mutant experiments, it provided yet another donor/acceptor configuration (with rhodamine phalloidin as a donor) for following actin regulatory transitions. Our results show no significant differences in energy transfer between rhodamine and ANP in any of the actin regulatory states, including the open state (Table II). These findings confirm our results obtained with AEDANS-labeled actin mutants, namely, that there seem to be no significant movements of subdomain 2 during actin regulation.

The labeling of the skeletal actin with ANP had the additional advantage of allowing us to arrest subdomain 2 movement through the cross-linking of Gln41 to Cys374 on adjacent protomers (18). We found that despite this modification, which significantly impairs the motility of F-actin, the thin filaments remained regulated. This outcome alone does not preclude subdomain 2 movement during regulation; it simply demonstrates that such movement is not a requirement for regulation, and it serves to reinforce our results from the previous experiments that indicate no discernible regulation-based subdomain 2 movements.

Care must always be exercised in interpreting data generated through the use of probes. Probes may affect the characteristics of their host proteins and alter the dynamic properties of mobile sites. In the case of labeled actins, probes may stabilize or destabilize DNase I loop/C terminus interactions, or even produce a particular conformation that may not reflect normal function. However, the fact that the probes did not introduce marked changes in the in vitro motility of the actins, and especially in the regulation of their acto-S1 ATPase activities, indicates that they do not introduce noteworthy changes in the actins. Moreover, our multiple experiments, each yielding similar results, suggest that subdomain 2 movements seem neither to occur during, nor play an important role in, the regulation of actin by tropomyosin and troponin.

    ACKNOWLEDGEMENT

We thank Mahta Nili for carrying out the in vitro motility measurements on the yeast actins.

    FOOTNOTES

* This work was supported by United States Public Health Service Grant AR-22031 and National Science Foundation Grant MCB 9904599 (to E. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Tel.: 310-825-2668; Fax: 310-206-7286; E-mail: reisler@mbi.ucla.edu.

Published, JBC Papers in Press, February 21, 2001, DOI 10.1074/jbc.M011070200

    ABBREVIATIONS

The abbreviations used are: Tm, tropomyosin; Tn, troponin; S1, myosin subfragment-1; DTT, dithiothreitol; ANP, azidonitrophenyl putrescine; IAEDANS, 5-(2((iodoacetyl)amino)ethyl)amino-naphthalene-1-sulfonate; F-actin, filamentous-actin; FRET, fluorescence energy transfer; TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Squire, J. M., and Morris, E. P. (1998) FASEB J. 12, 761-771[Abstract/Free Full Text]
2. Oosawa, F. (1983) in Muscle and Non-muscle Motility (Stracher, A., ed), Vol. 1 , pp. 151-216, Academic Press, New York
3. Orlova, A., and Egelman, E. H. (1993) J. Mol. Biol. 232, 334-341[CrossRef][Medline] [Order article via Infotrieve]
4. Miki, M., dos Remedios, C. G., and Barden, J. A. (1987) Eur. J. Biochem. 168, 339-345[Abstract]
5. Prochniewicz-Nakayama, E., Yanagida, T., and Oosawa, F. (1983) J. Cell Biol. 97, 1663-1667[Abstract]
6. Orlova, A., and Egelman, E. H. (1995) J. Mol. Biol. 245, 582-597[CrossRef][Medline] [Order article via Infotrieve]
7. Crosbie, R. H., Miller, C., Cheung, P., Goodnight, T., Muhlrad, A., and Reisler, E. (1994) Biophys. J. 67, 1957-1964[Abstract]
8. Strzelecka-Golaszewska, H., Wozniak, A., Hult, T., and Lindberg, U. (1996) Biochem. J. 316, 713-721[Medline] [Order article via Infotrieve]
9. Orlova, A., and Egelman, E. H. (1992) J. Mol. Biol. 227, 1043-1053[Medline] [Order article via Infotrieve]
10. Muhlrad, A., Cheung, P., Phan, B. C., Miller, C., and Reisler, E. (1994) J. Biol. Chem. 269, 11852-11858[Abstract/Free Full Text]
11. Tirion, M. M., ben-Avraham, D., Lorenz, M., and Holmes, K. C. (1995) Biophys. J. 68, 5-12[Abstract]
12. Owen, C., and DeRosier, D. (1993) J. Cell Biol. 123, 337-344[Abstract]
13. Lorenz, M., Poole, K. J., Popp, D., Rosenbaum, G., and Holmes, K. C. (1995) J. Mol. Biol. 246, 108-119[CrossRef][Medline] [Order article via Infotrieve]
14. Khaitlina, S. Y., Moraczewska, J., and Strzelecka-Golaszewska, H. (1993) Eur. J. Biochem. 218, 911-920[Abstract]
15. Mossakowska, M., Moraczewska, J., Khaitlina, S., and Strzelecka- Golaszewska, H. (1993) Biochem. J. 289, 897-902[Medline] [Order article via Infotrieve]
16. Hegyi, G., Premecz, G., Sain, B., and Muhlrad, A. (1974) Eur. J. Biochem. 44, 7-12[Medline] [Order article via Infotrieve]
17. Schwyter, D., Phillips, M., and Reisler, E. (1989) Biochemistry 28, 5889-5895[Medline] [Order article via Infotrieve]
18. Hegyi, G., Mak, M., Kim, E., Elzinga, M., Muhlrad, A., and Reisler, E. (1998) Biochemistry 37, 17784-17792[CrossRef][Medline] [Order article via Infotrieve]
19. Kim, E., and Reisler, E. (1996) Biophys. J. 71, 1914-1919[Abstract]
20. Kim, E., Wriggers, W., Phillips, M., Kokabi, K., Rubenstein, P. A., and Reisler, E. (2000) J. Mol. Biol. 299, 421-429[CrossRef][Medline] [Order article via Infotrieve]
21. Rayment, I., Holden, H. M., Whittaker, M., Yohn, C. B., Lorenz, M., Holmes, K. C., and Milligan, R. A. (1993) Science 261, 58-65[Medline] [Order article via Infotrieve]
22. Bertrand, R., Derancourt, J., and Kassab, R. (1994) FEBS Lett. 345, 113-119[CrossRef][Medline] [Order article via Infotrieve]
23. Kim, E., Miller, C. J., Motoki, M., Seguro, K., Muhlrad, A., and Reisler, E. (1996) Biophys. J. 70, 1439-1446[Abstract]
24. Lehman, W., Craig, R., and Vibert, P. (1994) Nature 368, 65-67[CrossRef][Medline] [Order article via Infotrieve]
25. Lehman, W., Vibert, P., Uman, P., and Craig, R. (1995) J. Mol. Biol. 251, 191-196[CrossRef][Medline] [Order article via Infotrieve]
26. Xu, C., Craig, R., Tobacman, L., Horowitz, R., and Lehman, W. (1999) Biophys. J. 77, 985-992[Abstract/Free Full Text]
27. Vibert, P., Craig, R., and Lehman, W. (1997) J. Mol. Biol. 266, 8-14[CrossRef][Medline] [Order article via Infotrieve]
28. Bonafé, N., Mathieu, M., Kassab, R., and Chaussepied, P. (1994) Biochemistry 33, 2594-2603[Medline] [Order article via Infotrieve]
29. Miller, C. J., Doyle, T. C., Bobkova, E., Botstein, D., and Reisler, E. (1996a) Biochemistry 35, 3670-3676[CrossRef][Medline] [Order article via Infotrieve]
30. Sikorski, R. S., Michaud, W. A., Tugendreich, S., and Hieter, P. (1995) Gene (Amst.) 155, 51-59[CrossRef][Medline] [Order article via Infotrieve]
31. Godfrey, J. E., and Harrington, W. F. (1970) Biochemistry 9, 886-893[Medline] [Order article via Infotrieve]
32. Spudich, J. A., and Watt, S. (1971) J. Biol. Chem. 246, 4866-4871[Abstract/Free Full Text]
33. Weeds, A. G., and Pope, B. (1977) J. Mol. Biol. 111, 129-157[Medline] [Order article via Infotrieve]
34. Kron, S. J., Toyoshima, Y. Y., Uyeda, T. Q., and Spudich, J. A. (1991) Methods Enzymol. 196, 399-416[Medline] [Order article via Infotrieve]
35. Cook, R. K., Root, D., Miller, C., Reisler, E., and Rubenstein, P. A. (1993) J. Biol. Chem. 268, 2410-2415[Abstract/Free Full Text]
36. Du, J., and Frieden, C. (1998) Biochemistry 37, 13276-13284[CrossRef][Medline] [Order article via Infotrieve]
37. Kim, E., and Reisler, E. (2000) Biophys. Chem. 86, 191-201[CrossRef][Medline] [Order article via Infotrieve]
38. Gerson, J. H., Bobkova, E., Homsher, E., and Reisler, E. (1999) J. Biol. Chem. 274, 17545-17550[Abstract/Free Full Text]
39. Stern, O., and Volmer, M. (1919) Phys. Z. 20, 183
40. Umemoto, S., and Sellers, J. R. (1990) J. Biol. Chem. 265, 14864-14869[Abstract/Free Full Text]
41. Homsher, E., Wang, F., and Sellers, J. R. (1992) Am. J. Physiol. 262, C714-C723[Abstract/Free Full Text]
42. Kim, E., Bobkova, E., Miller, C. J., Orlova, A., Hegyi, G., Egelman, E. H., Muhlrad, A., and Reisler, E. (1998) Biochemistry 37, 17801-17809[CrossRef][Medline] [Order article via Infotrieve]
43. Kim, E., Motoki, M., Seguro, K., Muhlrad, A., and Reisler, E. (1995) Biophys. J. 69, 2024-2032[Abstract]
44. Moraczewska, J., Strzelecka-Golaszewska, H., Moens, P. D., and dos Remedios, C. G. (1996) Biochem. J. 317, 605-611[Medline] [Order article via Infotrieve]
45. Doyle, T., Hansen, J. E., and Reisler, E. (2001) Biophys. J. 80, 427-434[Abstract/Free Full Text]
46. McKillop, D. F., and Geeves, M. A. (1993) Biophys. J. 65, 693-701[Abstract]
47. Wu, P., and Brand, L. (1994) Anal. Biochem. 218, 1-13[CrossRef][Medline] [Order article via Infotrieve]
48. Holmes, K. C., Popp, D., Gebhard, W., and Kabsch, W. (1990) Nature 347, 44-49[CrossRef][Medline] [Order article via Infotrieve]
49. Lorenz, M., Popp, D., and Holmes, K. C. (1993) J. Mol. Biol. 234, 826-836[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.